₹ 2,683 Cr
1.94%
BSE Healthcare TRI
INF769K01EB0
5000.0
1000.0
99
Vrijesh Kasera
Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
---|---|---|---|
Mirae Asset Healthcare Fund Regular IDCW | 13.85 | 22.58 | 20.59 |
Benchmark | - | - | - |
Equity
Debt
Others
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
Company | Holdings (%) |
---|---|
SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 11.41 |
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 7.65 |
AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 6.98 |
CIPLA LIMITED EQ NEW FV RS.2/- | 6.23 |
APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 5.76 |
GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/- | 5.49 |
LUPIN LIMITED EQ NEW F.V. RS.2/- | 5.41 |
Dr. Reddys Laboratories Ltd | 4.5 |
Krishna Institute Of Medical Sciences Limited | 4.15 |
SUVEN PHARMACEUTICALS LIMITED EQ | 3.88 |
Sector | Holdings (%) |
---|---|
Healthcare | 97.25 |
Chemicals | 1.35 |
Information Technology | 0.77 |
N/A | 0.63 |